Method for detecting nucleotide by using biological angstrom pore

By using a small conductivity mechanical force-sensitive channel Amypore system in nanopore detection technology, the pore size is adjusted using mechanical force and physical state changes, the problem of detecting molecules of multiple sizes in genetic testing is solved, and efficient and sensitive nuclear Glycolic detection.

CN119061124APending Publication Date: 2024-12-03SICHUAN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411186639.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2021-08-30
Filing Date
2022-06-29
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing nanopore detection technology has problems such as high cost, insufficient sensitivity and accuracy in genetic testing. The channel structure of protein nanopores is fixed, making it difficult to adapt to the detection of molecules of multiple sizes, and requires complex chemical modification or bioengineering technology. Pore ​​size adjustment.

Method used

The small conductivity mechanical force sensitivity channel (MscS) emime pore system is used to adjust the pore size through mechanical force stimulation and changes in the physical state of the insulating film, so as to realize direct detection and distinction of nucleotides. The pore size of the MscS emime pore is adjustable and side-hole charge variants improve detection selectivity.

Benefits of technology

It realizes efficient detection and distinction of multiple nucleotides, reduces detection costs, avoids the complexity of chemical modification in traditional technologies, and improves detection sensitivity and accuracy.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061124A_ABST
    Figure CN119061124A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of nanopore detection, and particularly relates to a method for detecting nucleotide by using a biological angstrom pore. The invention provides a method for detecting nucleotide in a sample, and the method comprises the following steps: S1, adding the sample into an angstrom pore system, the angstrom pore system comprises an angstrom pore, an insulating film, a first medium and a second medium, the angstrom pore is an MscS angstrom pore, the angstrom pore has a heptamer structure which is radially symmetrical and has a cylinder-like shape, and the insulating film is arranged in the first medium; the heptamer structure comprises seven side openings and one bottom opening; the sample is added to the first medium; s2, applying a driving force to the first medium and the second medium, wherein the nucleotide in the sample interacts with the angstrom hole and generates an electric signal; and S3, analyzing the electric signal so as to identify the nucleotide in the sample.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application based on the Chinese invention patent application with application number 202210784770.4, application date June 29, 2022, and invention name “A method for detecting nucleotides using biological angstrom pores”.

[0002] This application claims the priority of the Chinese invention patent application [CN2021110062606] filed on August 30, 2021, entitled “Biological nanopore system for dNTPs and new coronavirus detection based on PaMscS”, and the priority of the Chinese invention patent application [CN2021110042496] filed on August 30, 2021, entitled “Biological nanopore system for small molecule drug detection and whole blood detection based on PaMscS”. The two priority invention patent applications are incorporated by reference in their entirety. Technical Field

[0003] The invention belongs to the field of nanopore detection, and in particular relates to a method for detecting nucleotides using biological angstrom pores. Background Art

[0004] Nanopore single-molecule detection technology is a sensor detection technology that combines the advantages of simple operation, high sensitivity, fast detection speed, and no labeling. It is widely used in protein detection, gene sequencing, and marker detection. At present, the cost, sensitivity, and accuracy of gene detection are the main problems that need to be solved in the development of this detection technology. Therefore, the development of new nanopore materials is a key means to solve these problems.

[0005] A biological nanopore is a naturally formed nanoscale pore whose pore size is similar to the size of many important biological molecules. When a molecule passes through the channel inside the nanopore, a specific blockade current and translocation event are generated. According to the blockade current and translocation frequency of the molecule, qualitative and quantitative analysis of the target molecule can be achieved. Therefore, the channel pore size is the dominant factor affecting the detection ability and application range of the nanopore. Some protein nanopores with suitable channel pore sizes have been used for nanobiotechnology applications, such as α-hemolysin (α-HL), MspA, CsgG, Aerolysin, phi29 connector, etc. These biological nanopores are mainly derived from bacterial porins or viral phyla and have pore sizes (1.0nm-3.6nm) of the order of single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA). Therefore, they are suitable for detecting nucleic acids and have been used for DNA / RNA sequencing, nucleic acid biomarker detection and biomolecular interaction research. However, currently, biological nanopores need to be locally modified according to specific application requirements, such as site-directed mutagenesis or modification of specific adapters, in order to adapt to a wider range of sequencing. Taking α-HL as an example, its limited pore size is about 1.4nm, so its application range is limited to the analysis of ssDNA, RNA or other molecules. By modifying it with cyclodextrin, it can be used to directly detect monophosphate deoxyribonucleoside dNMPs without fluorescent labeling. However, changing the pore size of biological nanopores by modification requires a lot of bioengineering technology assistance. In addition, compared with solid-state nanopores, protein pores are much less flexible in adjusting size. In this sense, there is an urgent need to find a nanopore with a flexible structure to efficiently detect molecules of various sizes.

[0006] As the letters of the writing of life, the arrangement of single nucleotide dNTPs contains a huge amount of information. These versatility of dNTPs not only make them the components of genetic material, but also make them possible in DNA probes, species identification through DNA barcoding and efficient application of DNA computing. For the detection of dNTPs, traditional technologies include HPLC, fluorescence detection and qPCR, which often require fluorescent labeling or expensive equipment.

[0007] In summary, the present invention provides a method for detecting multiple nucleotides based on the small conductance mechanical force sensitive channel angstrom pore, which is a pore protein with a smaller size than nanopore, to improve the deficiencies of the prior art. Summary of the invention

[0008] In view of this, the present invention provides a method for detecting nucleotides in a sample, and the specific technical solution is as follows.

[0009] A method for detecting nucleotides in a sample, characterized in that it comprises the following steps: S1: adding the sample to an angstrom system, the angstrom system comprising: an angstrom, an insulating film, a first medium, and a second medium, wherein the angstrom is embedded in the insulating film, the insulating film separates the first medium from the second medium, the angstrom provides a channel connecting the first medium and the second medium, the angstrom is an MscS angstrom, the angstrom has a radially symmetrical and cylindrical heptamer structure, the heptamer structure comprises 7 side openings and 1 bottom opening; the sample is added to the first medium; S2 applies a driving force to the first medium and the second medium, and the nucleotides in the sample interact with the angstrom pore and generate an electrical signal; S3 analyzes the electrical signal to identify the nucleotides in the sample.

[0010] Furthermore, the charge properties and / or aperture sizes of the openings are adjustable.

[0011] Furthermore, the opening is adjusted in a manner including subjecting the insulating film to mechanical force stimulation and / or changing the physical state of the insulating film.

[0012] Furthermore, the mechanical force stimulation includes one or more of a change in the osmotic pressure difference of the medium on both sides of the insulating membrane, direct physical stimulation of the insulating membrane by a microneedle, and stimulation of the insulating membrane by negative air pressure.

[0013] Furthermore, the aperture of the opening can be adjusted according to the following methods: (1) Selection of the types of the first medium and the second medium; and / or (2) The osmotic pressure difference between the first medium and the second medium.

[0014] Furthermore, the osmotic pressure difference between the first medium and the second medium is adjusted by the concentration difference between the first medium and the second medium.

[0015] Further, the concentration difference between the first medium and the second medium is about 0-270 mM.

[0016] Furthermore, the angstrom pore is a MscS variant angstrom pore.

[0017] Furthermore, the MscS variants include side pore volume variants and / or side pore charge variants.

[0018] Furthermore, the angstrom is derived from Bacillus.

[0019] Furthermore, the angstroms include one or more of Pseudomonas aeruginosa, Escherichia coli, Tengchong thermophilic anaerobic bacteria and Helicobacter pylori.

[0020] Furthermore, the angstrom pore is a PaMscS variant angstrom pore. The mutation site of the PaMscS variant angstrom pore is located at the side opening of the cytoplasmic region of the PaMscS.

[0021] Furthermore, the PaMscS variant angstrom pore includes one or more of 130A, 130H, 180R, 271I, 130S and 130P.

[0022] Furthermore, the nucleotides include one or more of dGTP, dATP, dTTP, dCTP, dUTP, GTP, ATP, TTP, CTP, and UTP.

[0023] Furthermore, the insulating film includes a phospholipid membrane and / or a polymer membrane.

[0024] Furthermore, the first medium and / or the second medium includes one or more of a sodium chloride solution, a lithium chloride solution, a cesium chloride solution, a potassium chloride solution and a sodium bromide solution.

[0025] On the other hand, the present invention also provides a nucleotide rapid detection kit, characterized in that the kit comprises: (1) MscS angstrom pore; (2) Insulating film; (3) Conductive fluid.

[0026] Further, the MscS angstrom pore comprises side pore volume variants and / or side pore charge variants of MscS.

[0027] Furthermore, the insulating film includes a phospholipid membrane and / or a polymer membrane.

[0028] Furthermore, the conductive liquid includes one or more of a sodium chloride solution, a lithium chloride solution, a cesium chloride solution, a potassium chloride solution and a sodium bromide solution.

[0029] Furthermore, the MscS angstrom pore comprises a PaMscS variant angstrom pore.

[0030] Furthermore, the PaMscS variant angstrom pore includes one or more of 130A, 130H, 180R, 271I, 130S and 130P.

[0031] Compared with the prior art, the present invention has the following beneficial effects:

[0032] The present invention provides a method for detecting nucleotides in a sample using an angstrom pore system, wherein the angstrom pore system comprises an MscS angstrom pore. The present invention creatively utilizes the characteristics of a mechanosensitive channel of small conductance (MscS) to detect nucleotides in a sample, which is specifically embodied as follows:

[0033] 1) The pore size of the MscS angstrom pore is narrow. It is estimated that the pore size of the MscS angstrom pore ranges from 6 to 16 angstroms, which is much smaller than the nanopores commonly used in the prior art (for example, the pore size of the α-hemolysin nanopore is about 1.4-2.4 nm, i.e., 14–24 angstroms).

[0034] 2) The pore size of the MscS angstrom pore is adjustable (it can also be understood as a flexible structure). The MscS angstrom pore can convert mechanical stimulation into electrical or biochemical signals within milliseconds, thereby inducing the regulation of the channel configuration. By utilizing the sensitivity of the MscS angstrom pore to the mechanical force stimulation and / or the change in the physical state of the insulating membrane, the pore size of the MscS angstrom pore can be adjusted by affecting the insulating membrane without complicated chemical modification. For example, the concentration of the first medium and the second medium (i.e., 30mM NaCl / 300mM NaCl, 100mM NaCl / 300mM NaCl and 300mM NaCl / 300mMNaCl) can be adjusted to adjust the osmotic pressure difference on both sides of the insulating membrane and then adjust the pore size, thereby optimizing the selectivity for dNTPs and improving the distinction between dNTPs. Protein nanopores in the prior art usually have a fixed channel structure, and direct detection of nucleotides (e.g., dNTPs and similar molecules) usually requires additional protein engineering modification or chemical modification. The pore size of the MscS angstrom pore involved in the present invention can be reversibly adjusted in situ simply by changing the external conditions, and is suitable for direct single-molecule sensing and recognition of nucleotides (which can also be understood as direct detection of nucleotides).

[0035] 3) The method provided by the present invention can directly detect and distinguish one or more nucleotides, and can also be used in combination with other strategies to further detect whether the target nucleic acid exists in the sample. In addition, mutations can be introduced into the side holes of the MscS angstrom pore to adjust the volume (e.g., replacing W with A, S, P) and charge (e.g., replacing W with H, replacing K with R) of the amino acids at the side holes to achieve better detection of specific charged molecules and molecules of specific sizes.

[0036] As used herein, the term "derived from" refers not only to proteins produced by the strain of the organism in question, but also to proteins encoded by a DNA sequence isolated from such strain and produced in a host organism containing such DNA sequence. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the following briefly introduces the drawings required for use in the embodiments or the prior art descriptions. Obviously, the drawings described below are some embodiments of the present invention, and for ordinary technicians in this field, other drawings can be obtained based on these drawings without creative labor.

[0038] Figure 1 Electrophysiological testing and dNTP detection based on PaMscS angstrom pores are shown;

[0039] Figure 2 The transport frequency of dNTPs through the PaMscS1 pore under different osmotic pressure differences is shown;

[0040] Figure 3 Detection of AFP aptamer and miR21 by dNTPs consumption by PaMscS1 is shown;

[0041] Figure 4 The SDS-PAGE results of PaMscS proteins (including: 1: wild-type PaMscS; 2: W130A mutant; 3: K180R mutant; 4: marker) are shown;

[0042] Figure 5 The current signal or current distribution of wild-type or mutant PaMscS is shown;

[0043] Figure 6 shows the current trace through a single PaMscS1 angstrom pore under a ramp voltage from 0 mV to +100 mV;

[0044] Figure 7 The transport capacity of different ions through the PaMscS1 pore is shown;

[0045] Figure 8 The translocation frequency statistics of dNTPs through the PaMscS1 angstrom pore at different voltages are shown (n=3);

[0046] Fig. 9 The current trace and dwell time distribution of single nucleotide detection by PaMscS1 are shown;

[0047] Fig.10 It was shown that single-stranded DNA cannot translocate through the PaMscS1 pore;

[0048] Fig.11 The results of native PAGE electrophoresis of PCR reagents mixed with miR21 and AFP aptamers are shown;

[0049] Fig.12dNTP detection based on wild-type PaMscS angstrom pore is shown;

[0050] Fig.13 Single channel embedded current traces of wild-type EcMscS are shown (voltage +100 mV, conductance solution 30 mM:300 mM NaCl);

[0051] Fig.14 Channel scanning voltage (−100 mV to 100 mV) of wild-type EcMscS is shown;

[0052] Fig.15 The conductance distribution of wild-type EcMscS is shown;

[0053] Fig.16 Shown is a sequence alignment of PaMscS with MscS from other bacteria. DETAILED DESCRIPTION

[0054] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0055] It should be noted that, in this article, the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, an element defined by the sentence "comprises a ..." does not exclude the existence of other identical elements in the process, method, article or device including the element.

[0056] As used in this specification, the term "about" typically means + / - 5% of the stated value, more typically + / - 4% of the stated value, more typically + / - 3% of the stated value, more typically + / - 2% of the stated value, even more typically + / - 1% of the stated value, and even more typically + / - 0.5% of the stated value.

[0057] In this specification, certain embodiments may be disclosed in a format of being in a certain range. It should be understood that such description of "being in a certain range" is merely for convenience and brevity, and should not be interpreted as a rigid limitation on the disclosed range. Therefore, the description of the range should be considered to have specifically disclosed all possible sub-ranges and independent numerical values ​​within this range. For example, the description of the range 1 to 6 should be considered to have specifically disclosed sub-ranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., as well as individual numbers within this range, such as 1, 2, 3, 4, 5 and 6. Regardless of the breadth of the range, the above rules apply.

[0058] Detailed description of the drawings

[0059] Figure 1 : A. Schematic diagram of the electrophysiological measurement chamber. B. Single-hole insertion of PaMscS1 and PaMscS2 angstrom pores at a voltage of +50 mv. C. IV relationship of PaMscS1 and PaMscS2 angstrom pores in the voltage range of -50 mv to +50 mv. D. Conductance distribution of PaMscS1 and PaMscS2 angstrom pores (N=18, respectively) (buffer conditions are -cis end: 300 mM NaCl, -trans end: 30 mM NaCl). E. Detection of dNTPs through PaMscS mutant angstrom pores (buffer conditions are -cis end: 300 mM NaCl, -trans end: 30 mM NaCl, and voltage is +50 mv).

[0060] Figure 2 : The translocation frequencies of dCTP (in orange) and dGTP (in blue) were tested under different osmotic pressure difference conditions, symmetric (A, 300mM NaCl: 300mM NaCl for cis end: trans end), low osmotic pressure difference (LOD) (B, 300mM NaCl: 100mM NaCl for cis end: trans end), and high osmotic pressure difference (HOD) (C, 300mM NaCl: 30mM NaCl for cis end: trans end). Four groups of dNTPs concentrations, 0.5mM, 1.0mM, 1.5mM, and 2.0mM, were used to test the translocation of dCTP and dGTP. D. The relationship between the translocation frequency and the dCTP / dGTP concentration under symmetric, low osmotic pressure difference, and high osmotic pressure difference conditions (n=3 for each data point). E. Under 3 different osmotic pressure difference conditions, f dCTP and f dGTP rate of increase.

[0061] Figure 3:A. Schematic diagram of the detection strategy. B. Current traces of the no-target control group, miR21 group, AFP aptamer group, and group with both miR21 and AFP aptamer. C. Current distribution of the four detection groups. D. Relative increase of dATP and dGTP signals in the four groups. Samples without miR21 and AFP aptamer will not lead to dNTPs consumption; samples with miR21 will lead to more dATP consumption and relatively lower dATP translocation frequency; samples with AFP aptamer will lead to more dGTP consumption and relatively lower dGTP translocation frequency; samples with both miR21 and AFP aptamer will lead to more dATP and dGTP consumption and relatively lower dATP and dGTP translocation frequency (buffer conditions are -cis end: 300mM NaCl, -trans end: 100mM NaCl, voltage is +50mV, n=3 for each experiment).

[0062] Figure 5 :A. Background signal frequency of wild-type PaMscS and mutant PaMscS1 and PaMscS2. The background noise frequency of PaMscS1 and PaMscS2 is lower than that of wild-type PaMscS (voltage is +50mv, n≥3). B. Time of insertion of PaMscS1 and PaMscS2 angstrom pores. PaMscS2 angstrom pores have higher membrane fusion efficiency than PaMscS1 (n≥3). C. dNTPs blocking current distribution of PaMscS1 and PaMscS2 angstrom pores.

[0063] Figure 6 : Current trace through a single PaMscS1 angstrom pore under a ramp voltage from 0 mV to +100 mV: Voltage gating was observed when the voltage was increased above +90 mV (buffer conditions were -cis end: 300 mM NaCl, -trans end: 30 mM NaCl, sampling frequency: 4999 Hz).

[0064] Figure 7 : Buffer conditions were: 300 mM NaCl on the -cis side, 30 mM NaCl on the -trans side, n ≥ 3 for each data point, mean ± SD.

[0065] Fig. 9 : Residence time distribution: of dGTP (A), dATP (B), dTTP (C) and dCTP (D); the concentration of each nucleotide was 2 mM and the buffer conditions were -cis end: 300 mM NaCl, -trans end: 30 mM NaCl, voltage was +50 mV.

[0066] Fig.10: Voltage: +50 mV; Buffer conditions: 300 mM NaCl on the cis side, 30 mM NaCl on the trans side. The final concentration of ssDNA was 5 μM, and the sequence was 5′TAGCTTATCAGACTGATGTTGA 3′ (SEQ ID NO: 5).

[0067] Fig.11 : 1: DNA template 1 (containing poly T); 2: DNA template 2 (containing poly C); 3: PCR reagents with miR21 and AFP adaptors; 4: control group (without miR21 and AFP adaptors).

[0068] Emikoon

[0069] The angstrom used in the present invention is a small conductance mechanosensitive channel (Mechanosensitive channel of small conductance, MscS), preferably PaMscS (Pseudomonas aeruginosa small conductance mechanosensitive channel) or its variant. The variant (also understood as a "mutant") can be a naturally occurring variant expressed by an organism (e.g., Pseudomonas aeruginosa). Variants also include non-naturally occurring variants produced by recombinant technology. In the present invention, "PaMscS variant", "mutant PaMscS", "mutant PaMscS", "PaMscS mutant" have the same meaning unless otherwise indicated.

[0070] In one embodiment of the present invention, the angstrom pore may be an MscS variant. Amino acid substitutions may be made to the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2 or SEQ ID NO: 3 or SEQ ID NO: 4, for example, single or multiple amino acid substitutions. The substitution may be a conservative substitution or a non-conservative substitution. Preferably, non-conservative substitutions may be made to one or more positions of the amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 2 or SEQ ID NO: 3 or SEQ ID NO: 4, wherein the substituted amino acid residues are replaced by amino acids with significantly different chemical properties and / or physical sizes. Further, the MscS variants may be divided into side pore volume variants and side pore charge variants. Side pore volume variants refer to variants in which the mutation site is located at the side opening of the cytoplasmic end (also understood as a "side pore") and the side pore volume is changed by changing the amino acid at the site. Side pore charge variants refer to variants in which the mutation site is located at the side opening of the cytoplasmic end and the side pore charge is changed by changing the amino acid at the site. For example, the side pore volume variant may be a replacement of a larger amino acid (e.g., tryptophan (W)) with a smaller amino acid (e.g., alanine (A), serine (S) or proline (P)), or vice versa. Side pore charge variants may be a replacement of an amino acid with a certain charge with an oppositely charged or neutral amino acid, or a replacement of a neutral amino acid with a charged amino acid. In general, non-limiting examples of positively charged amino acids include histidine, arginine and lysine; non-limiting examples of negatively charged amino acids include aspartic acid and glutamic acid; non-limiting examples of neutral amino acids include glycine, alanine, phenylalanine, valine, leucine, isoleucine, cysteine, asparagine, glutamine, serine, threonine, tyrosine, methionine, proline and tryptophan. Conservative or non-conservative substitutions of amino acids, as well as many different types of modifications (deletions, substitutions, additions) of amino acids are well known in the art, and those skilled in the art can modify MscS according to actual conditions to obtain corresponding MscS variants. The modification means include modifying the corresponding DNA sequence (for example, directly synthesizing the corresponding protein after modifying the DNA sequence information or performing site-directed mutation on the DNA sequence using PCR) to obtain the corresponding variant (and its corresponding DNA sequence).

[0071] In a specific embodiment, the MscS variant can be a PaMscS variant. The PaMscS variant includes, for example, one or more of 130A, 130H, 180R, 271I, 130S and 130P. The side pore volume mutants of PaMscS include, for example, 130A, 130S, 130P, and the side pore charge variants of PaMscS include, for example, 130H, 180R, 271I. Such modification can change the pore size (also understood as "pore size") of the modified side pore, thereby improving the detection capability of analytes of a specific molecular volume; it can also change the local charge characteristics of the modified side pore channel, thereby improving the detection capability of specific charged analytes; it can also enhance the stability of the protein channel current of the PaMscS variant.

[0072] In one embodiment of the present invention, the angstrom pore may be a wild-type PaMscS, which has a high background noise but still has the ability to detect analytes.

[0073] In one embodiment of the present invention, the angstrom pore may be a wild-type EcMscS (small conductance mechanosensitive channel of Escherichia coli) or a variant thereof. The structures of EcMscS and PaMscS are highly similar, and they can also form a stable channel current and have the ability to detect analytes. The sequence similarity between PaMscS and EcMscS is 60%. Conservative or non-conservative substitutions of amino acids, as well as many different types of modifications (deletions, substitutions, additions) of amino acids are well known in the art, and those skilled in the art can modify EcMscS according to actual conditions to obtain corresponding EcMscS variants.

[0074] In another embodiment of the present invention, in addition to Escherichia coli and Pseudomonas aeruginosa, the angstrom can also be derived from other bacilli, such as Thermoanaerobacter tengcongensis and Helicobacter pylori. The structures of PaMscS, TtMscS and HpMscS are also highly similar, and the sequence similarities are 55% and 44%, respectively. Combining the actual electrophysiological detection results of PaMscS and EcMscS, it can be seen that the reason why MscS can be used as an angstrom detection analyte is its highly similar structure and similar function. Conservative substitution or non-conservative substitution of amino acids, as well as many different types of modifications (deletion, substitution, addition) of amino acids are well known in the art, and those skilled in the art can modify MscS according to actual conditions to obtain corresponding MscS variants.

[0075] Analytes

[0076] The analyte is a charged substance. If the analyte has a net charge, it is charged. The analyte can be negatively charged or positively charged. If the analyte has a net negative charge, it is negatively charged. If the analyte has a net positive charge, it is positively charged. Suitable analytes should be substances with a size less than or equal to the pore size of the angstrom pore, preferably nucleotides, amino acids, peptides, drug molecules.

[0077] In one embodiment of the present invention, the analyte can be a nucleotide. "Nucleotide" refers to a monomeric unit consisting of a heterocyclic base, a sugar and a phosphate group. It should be understood that the heterocyclic base includes naturally occurring bases (guanine (G), adenine (A), cytosine (C), thymine (T) and uracil (U)) and non-natural base analogs. Sugar includes naturally occurring sugars (deoxyribose and ribose) and non-natural sugar analogs. The nucleotide includes deoxyribonucleotides and ribonucleotides, such as ATP, dATP, CTP, dCTP, GTP, dGTP, UTP, TTP, dUTP, GMP, UMP, TMP, CMP, dGMP, dAMP, dTMP, dCMP, dUMP, ADP, GDP, TDP, UDP, CDP, dADP, dGDP, dTDP, dUDP, dCDP. The nucleotide includes naturally occurring nucleotides and non-natural nucleotide analogs that hybridize with nucleic acids in a manner similar to naturally occurring nucleotides. The nucleotide is free (or can be understood as "single"). Preferably, the nucleotide is ATP, dATP, CTP, dCTP, GTP, dGTP, UTP, TTP, dUTP.

[0078] Angstrom pore system

[0079] The "Angstrom pore system" includes a pore with an Angstrom size (abbreviated as "Angstrom pore"), an insulating membrane, a first medium and a second medium. In one embodiment of the present invention, the pore with an Angstrom size is a small conductance mechanosensitive channel (MscS) Angstrom pore. The pore with an Angstrom size is preferably a heptameric structure with radial symmetry and a cylindrical shape, and the heptameric structure includes 7 side openings and 1 bottom opening. In one embodiment of the present invention, the pore with an Angstrom size has a typical heptameric structure with radial symmetry and a cylindrical shape, and the heptameric structure includes 8 openings, of which 7 equal openings are distributed on the side, and the 8th opening is distributed on the bottom and is formed by 7 subunits; the pore sizes of the above 8 openings can be adjusted. The pore with an Angstrom size allows the analyte to translocate from one side of the insulating membrane to the other side.

[0080] In one embodiment of the present invention, the pores with angstrom size are embedded in the insulating film, and the insulating film (which can also be understood as a complex of the pores with angstrom size and the insulating film) separates the first medium from the second medium, and the pores with angstrom size provide a channel connecting the first medium and the second medium; after applying a driving force between the first medium and the second medium, the analyte located in the first medium interacts with the MscS angstrom pore to form a current (i.e., an electrical signal). In the present invention, the "first medium" refers to the medium where the analyte is located when it is added to the angstrom pore system; the "second medium" refers to the other side of the "first medium" in the two parts of the medium separated by the insulating film. In the present invention, the driving force refers to the force that drives the analyte to interact with the angstrom pore by means of electric potential, electroosmotic flow, concentration gradient, etc.

[0081] The first medium and the second medium may be the same or different, and the first medium and the second medium may include a conductive liquid. The conductive liquid is an aqueous solution of alkali metal halides, specifically sodium chloride (NaCl), lithium chloride (LiCl), cesium chloride (CsCl), potassium chloride (KCl), sodium bromide (NaCl). In one embodiment of the present invention, the concentrations of the conductive liquids contained in the first medium and the second medium are different. In other words, there is a difference in the concentration of the conductive liquid in the first medium and the second medium, which results in a difference in the osmotic pressure on both sides of the insulating membrane. The first medium and / or the second medium may also include a buffer, such as HEPES. The concentration range of the first medium and / or the second medium may be 30mM-3M.

[0082] The insulating membrane refers to a membrane having the ability to carry angstrom pores (or nanopores) and block the ionic current passing through non-angstrom pores (or nanopores). The insulating membrane may include a phospholipid membrane and / or a polymer membrane. Exemplary insulating membranes include DPHPC, DOPC, E. coli lipid, and exemplary polymer membranes include triblock copolymer polymer membranes.

[0083] The present angstrom pore system may comprise any small conductance mechanosensitive channel described herein, such as wild-type PaMscS (SEQ ID NO: 1), wild-type EcMscS (SEQ ID NO: 2), wild-type TtMscS (SEQ ID NO: 3) and wild-type HpMscS (SEQ ID NO: 4) and their corresponding variants, and the specific sequence information of the above four MscS is shown in Table 3. For example, the small conductance mechanosensitive channel may be mutant PaMscS1 (W130A), mutant PaMscS2 (K180R), mutant PaMscS3 (V271I) (which has the ability to detect small molecule drugs, experimental data not shown).

[0084] In a specific embodiment of the present invention, the angstrom system includes two electrolyte chambers, which are separated by an insulating membrane to form a trans compartment and a cis compartment, and the holes of the angstrom are embedded in the insulating membrane, and there are only small-conductance mechanical force-sensitive channels, angstroms, on the insulating membrane to connect the two electrolyte chambers. When an electric potential is applied to the two electrolyte chambers, the electrolyte ions in the solution in the electrolyte chambers move by electrophoresis and pass through the angstrom pores.

[0085] In one embodiment of the present invention, the small conductance mechanosensitive channel (MscS) angstrom pore can be embedded in an insulating membrane, but it retains the ability to change the protein structure in response to mechanical force stimulation of the insulating membrane and changes in the physical state of the insulating membrane. Specifically, mechanical force stimulation includes changes in osmotic pressure on both sides of the insulating membrane, direct physical stimulation of the insulating membrane by microneedles, stimulation of the insulating membrane by negative air pressure, etc. The physical changes of the insulating membrane include changes in the thickness of the insulating membrane, changes in the composition of the insulating membrane, and changes in the surface curvature of the insulating membrane. The change in protein structure includes changing the charge properties and / or pore size of the opening of MscS. Further, the charge properties and / or pore size of the opening changed by the MscS angstrom pore can be used to detect different analytes. The adjustable range of the pore size of the angstrom pore involved in the present invention can be 5-15 angstroms.

[0086] The interaction between the angstrom pore and the analyte

[0087] The analyte may contact the angstrom pore on either side of the insulating film. The analyte may contact either side of the insulating film so that the analyte passes through the channel of the angstrom pore to reach the other side of the insulating film. In this case, the analyte interacts with the angstrom pore when it passes through the insulating film via the channel of the pore. Alternatively, the analyte may contact the side of the insulating film, which may allow the analyte to interact with the angstrom pore, separate from the angstrom pore and remain on the same side of the insulating film. The analyte may interact with the angstrom pore in any manner and at any site. The analyte may also hit the angstrom pore, interact with the angstrom pore, separate from the angstrom pore and remain on the same side of the insulating film.

[0088] During the interaction between the analyte and the angstrom pore, the analyte affects the current flowing through the angstrom pore in a manner specific to the analyte, i.e., the current flowing through the angstrom pore is characteristic for the specific analyte. A control experiment can be performed to determine the effect of a specific analyte on the current flowing through the angstrom pore, and then to identify the specific analyte in the sample or determine whether the specific analyte is present in the sample. More specifically, the current pattern obtained by detecting the analyte can be compared with a known current pattern obtained under the same conditions using a known analyte to identify the presence or absence of the analyte or the concentration, etc.

[0089] The angstrom pore system of the present invention may further include one or more measuring devices for measuring the current flowing through the angstrom pore, such as a patch clamp amplifier or a data acquisition device.

[0090] sample

[0091] The analyte may be present in any suitable sample. The present invention is typically performed on a sample known to contain or suspected of containing the analyte. The present invention may be performed on a sample containing one or more analytes of unknown species. Alternatively, the present invention may confirm the species of the one or more analytes known to be present or expected to be present in the sample.

[0092] The sample can be a biological sample. The present invention can be performed in vitro on a sample obtained from or extracted from any organism or microorganism. The present invention can also be performed in vitro on a sample obtained from or extracted from any virus. Preferably, the sample is a fluid sample. The sample generally includes body fluids. The sample can be a body fluid sample, such as urine, blood, serum, plasma, lymph, cyst fluid, pleural fluid, ascites fluid, peritoneal fluid, amniotic fluid, epididymal fluid, cerebrospinal fluid, bronchoalveolar lavage fluid, breast milk, tears, saliva, sputum or a combination thereof. The sample can be derived from humans or other mammals. The sample can be a non-biological sample. The non-biological sample is preferably a fluid sample, such as drinking water, sea water, river water and reagents for laboratory tests.

[0093] The sample may not be processed before analysis, for example, the analyte may be detected directly in whole blood. The sample may also be processed before analysis, for example, by centrifugation, filtration, dilution, precipitation or other physical or chemical means known in the art.

[0094] In one embodiment of the present invention, the sample is a nucleic acid amplification product.

[0095] Method for detecting the presence of nucleic acid in a sample

[0096] The present invention also provides a method for detecting the presence of nucleic acid in a sample. The method comprises: S1 placing a sample in a nucleic acid amplification system and performing nucleic acid amplification, determining the number of substrate nucleotides in the nucleic acid amplification system, and obtaining a nucleic acid amplification product of the sample; S2 adding the nucleic acid amplification product of the sample to an angstrom pore system, wherein the angstrom pore system comprises: an angstrom pore, an insulating membrane, a first medium, and a second medium, wherein the protein angstrom pore is embedded in the insulating membrane, the insulating membrane separates the first medium from the second medium, the angstrom pore provides a channel connecting the first medium and the second medium, the angstrom pore is an MscS angstrom pore, the angstrom pore has a radially symmetrical and cylindrical heptamer structure, the heptamer structure comprises 7 side openings and 1 bottom opening, and the nucleic acid amplification product of the sample is added to the first medium; S3 applying a driving force between the first medium and the second medium, the remaining nucleotides in the nucleic acid amplification product of the sample interact with the angstrom pore and generate an electrical signal (current); S4 quantifying the electrical signal to obtain the number of the remaining nucleotides; S5 comparing the number of the remaining nucleotides with the number of the substrate nucleotides to determine whether the target nucleic acid exists in the sample. In some embodiments, S1 and S2 can be performed simultaneously or in the same system. Before detection, a threshold value can also be set. For example, only when the number of at least one of the remaining nucleotides is lower than the threshold value, the target nucleic acid is considered to be present in the sample; or only when the number of all types of remaining nucleotides is higher than the threshold value, the target nucleic acid is considered to be absent in the sample.

[0097] The "depletion strategy" of the present invention is actually applicable to a variety of transmembrane pores, and is not limited to the angstrom pores of the present invention. Those skilled in the art can select other transmembrane pores capable of detecting (and distinguishing) different nucleotides to detect the presence or absence of the target nucleic acid based on their understanding of the present invention.

[0098] "Nucleic acid" refers to a deoxyribonucleotide or ribonucleotide polymer in single-stranded or double-stranded form. "Nucleic acid amplification" of a target nucleic acid refers to the process of constructing a nucleic acid chain in vitro that is identical or complementary to at least a portion of the target nucleic acid sequence. The nucleic acid amplification process can only occur when the target nucleic acid is present in the sample. In the nucleic acid amplification process, enzymes (such as nucleic acid polymerases, transcriptases) are usually used to produce multiple copies of the target nucleic acid or its fragments, or multiple copies of a sequence complementary to the target nucleic acid or its fragments. After the nucleic acid amplification process occurs, the substrate nucleotides of the nucleic acid amplification system will decrease accordingly as the number of copies increases. For example, Figure 3 A shows a nucleic acid amplification system.

[0099] The principle of the method of the present invention is based on in vitro nucleic acid amplification technology to consume substrate nucleotides in the nucleic acid amplification system. Therefore, common in vitro nucleic acid amplification technologies, such as polymerase chain reaction (PCR), ligase chain reaction (LCR), strand displacement amplification technology (SDA), transcription-mediated amplification technology (TMA), and loop-mediated isothermal amplification technology (LAMP) can be used in conjunction with the method provided by the present invention.

[0100] In a specific embodiment, the method provided by the present invention can detect whether the new coronavirus nucleic acid is present in a sample.

[0101] In a specific embodiment, the method provided by the present invention can detect whether single-stranded nucleic acid exists in a sample.

[0102] In one embodiment of the present invention, the present invention constructs suitable primers (e.g., specific primers for SARS-CoV-2 nucleic acid) and introduces the primers into a nucleic acid amplification system (including substrate dNTPs, polymerase, reverse transcriptase). If the novel coronavirus nucleic acid is present in the sample, the novel coronavirus nucleic acid is amplified under suitable conditions, consuming the substrate dNTPs and generating multiple copies of the nucleic acid. After the nucleic acid amplification product of the sample is added to the angstrom pore system provided by the present invention, the macromolecular substances (e.g., enzymes, polynucleotides, etc.) in the nucleic acid amplification system cannot pass through the angstrom pore, that is, only free mononucleotides in the nucleic acid amplification system can pass through the angstrom pore and generate a specific current, thereby determining the number of remaining nucleotides to determine whether the target novel coronavirus nucleic acid is present in the sample (i.e., if there is no target novel coronavirus nucleic acid in the sample, the number of remaining nucleotides is closer to the number of substrate nucleotides before nucleic acid amplification; if there is novel coronavirus nucleic acid in the sample, the number of remaining nucleotides is significantly lower than the number of substrate nucleotides before nucleic acid amplification, and more specifically, at least one nucleotide in the substrate nucleotide may be completely consumed).

[0103] In one embodiment of the present invention, the present invention constructs a suitable probe (for example, the probe includes a sequence complementary to the target nucleic acid sequence and a polynucleotide sequence) and introduces the probe into a nucleic acid amplification system (including substrate dNTPs and polymerase). If the target nucleic acid sequence exists in the sample, the target nucleic acid sequence is amplified under suitable conditions to consume substrate dNTPs and generate multiple copies of the target nucleic acid sequence; more specifically, since the probe also has a polynucleotide sequence (for example, PolyT, PolyA, Poly C, Poly G), after the target nucleic acid sequence binds to the probe, a large amount of substrate nucleotides corresponding to the polynucleotide sequence will be consumed. Therefore, the specific consumption of a certain substrate nucleotide can be used to determine whether the target nucleic acid sequence exists in the sample. After the nucleic acid amplification product of the sample is added to the angstrom pore system provided by the present invention, the macromolecular substances (e.g., enzymes, polynucleotides, etc.) in the nucleic acid amplification system cannot pass through the angstrom pore, that is, only free mononucleotides in the nucleic acid amplification system can pass through the angstrom pore and generate specific current, thereby determining the number of remaining nucleotides to determine whether the target nucleic acid sequence exists in the sample (i.e., if there is no target nucleic acid sequence in the sample, the number of remaining nucleotides is closer to the number of substrate nucleotides before nucleic acid amplification; if there is a target nucleic acid sequence in the sample, the number of remaining nucleotides is significantly lower than the number of substrate nucleotides before nucleic acid amplification and the corresponding polynucleotides in the probe are consumed in large quantities. Based on this, different probes can be designed to simultaneously detect different target nucleic acid sequences in the same nucleic acid amplification system.

[0104] Specific implementation examples:

[0105] Embodiment 1

[0106] Materials and Methods

[0107] Sodium chloride (NaCl, >99.0%, CAS#7647-14-5), dNTP mixture (>99.0%), dATP (>97%, CAS#1927-31-7), dCTP (>98%, CAS#102783-51-7), dGTP (>98%, CAS#93919-41-6), and dTTP (>98%, CAS#18423-43-3) were purchased from Sangon Biotech. Yeast extract (CAS#8013-01-2), trypsin (CAS#73049-73-7), ampicillin sodium salt (≥98.5%, CAS#69-52-3), Tris (≥99.9%, CAS#77-86-1), imidazole (≥99%, CAS#288-32-4), dodecyl-β-D-maltopyranoside (DDM) (≥99%, CAS#69227-93-6), isopropyl-β-D-thiogalactoside (IPTG) (≥99%, CAS#367-93-1), phenylmethylsulfonyl fluoride (Phenylmethylsulfonyl fluoride) fluoride, PMSF) (≥99.%, CAS#329-98-6), 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) (>99.5%, CAS#7365-45-9) were purchased from Sigma-Aldrich. Escherichia coli extracted phospholipids were purchased from Avanti. PrimeSTAR HSDNA polymerase was purchased from TaKaRa. pUC57 vector plasmid, DNA template, miRNA-21, and AFP aptamer were synthesized by Sangon Biotech, and their sequence information is listed in Table 1.

[0108] Table 1 Sequences of miR21 and AFP aptamers

[0109] Expression and purification of wild-type and mutant PaMscS:

[0110] The gene of PaMscS from the genomic DNA of Pseudomonas aeruginosa was amplified by polymerase chain reaction (PCR) using gene-specific primers. The gene was inserted into the plasmid using ClonExpress II One Step Cloning Kit (Vazyme). Escherichia coli BL21 (DE3) cells containing the plasmid of the PaMscS gene were cultured and expressed and purified in Luria-Bertani (LB) medium at 37°C in the presence of 50 μg / mL ampicillin. The peak value was determined by SDS-PAGE analysis. It is particularly noted that the expression and purification steps of the wild-type and mutant proteins in the present invention are the same, except that there are sequence differences between the wild-type protein and the mutant protein, so there are differences in the plasmid synthesis stage.

[0111] The experimental team of the present invention revealed the structure of the protein angstrom pore through modeling, which is a typical heptamer with radial symmetry and cylinder-like shape. It contains 8 openings, 7 on the side and 1 at the bottom. The N-terminal residues 1-13 are too flexible to be resolved in the model. Topologically, PaMscS can be divided into two parts, the transmembrane region and the large cytoplasmic part. Each monomer produces three N-terminal transmembrane helices, including TM1 (residues 17-52), TM2 (residues 58-83) and TM3 (residues 90-122). The C-terminal cytoplasmic region can be divided into the middle β domain and the COOH terminal domain. TM1 and TM2 in each subunit are arranged together in an antiparallel direction, TM1 passes through the double membrane outside the channel and TM2 forms the central layer, thus forming a permeation path around the channel axis. The TM3 helix can be described as two helical fragments, TM3a and TM3b, separated by a distinct kink (kink) ~53° at Gly108, which is a conserved residue in homology. TM3a, like TM1, passes through the membrane with a different deflection, while TM3b returns to the cytoplasm and interacts with the cytoplasmic region. In addition, the seven subunits form a The central pore senses tension and is associated with conformational changes. Comparing the MscS structures of Pseudomonas aeruginosa and Escherichia coli, the tilt angles of TM1 and TM2 of the former are smaller than those of the latter, which leads to a large deflection of the TM region, especially the loop between TM1 and TM2. In the cytoplasmic region, the middle β domain (residues 123-172) contains 5 β chains, which are tightly connected to the β chains of other different subunits. And the C-terminal domain (residues 177-273) is composed of 5 β chains and 2 α helices, which is a mixed structure. Between these two domains of adjacent monomers, there are 7 equal openings on the side, which are clearly visible, with a radius of about It is proposed to be responsible for ion permeation in EcMscS. In addition to these portals, an eighth opening exists at the base of the protein, represented by seven β-strands with a narrowest radius of In all sizes, extending to The PaMscS2 is parallel to the sevenfold axis and has a width in the perpendicular direction. The structure of PaMscS is similar to that of EcMscS in the closed state (PDB: 2OAU), and the TM domain has more than 101 rmsd. C α atoms, but in the open state (PDB: 2VV5), there is a large difference in the TM region, with an rmsd of These results suggest that the conformation of PaMscS in the structure reflects the closed state. Overall, the unique and elaborate structure of the PaMscS angstrom pore shows great potential for detection.

[0112] Site mutation:

[0113] The DNA sequence corresponding to the corresponding amino acid site is modified (including direct synthesis or PCR mutation after DNA sequence modification), and the DNA sequence at the target mutation site is modified to the DNA sequence corresponding to the mutant protein. The mutant protein of the mutant PaMscS protein angstrom may include 130A, 130H, 180R, 271I, 130S or 130P.

[0114] Merging and single channel recording of membranes:

[0115] The experiments were performed in a vertical sample cell provided by Warner Instruments. If not otherwise specified, all current traces were recorded by a HEKA EPC 10USB patch clamp amplifier with a sampling frequency of 9900 Hz. 1 μL of 25 mg / mL E. coli membrane was pre-coated on the 150 μm orifice of the cup, and then 1 mL of electrolyte solution (-trans end: 100 mM NaCl, 10 mM HEPES, pH 7.0; -cis end: 300 mM NaCl, 10 mM HEPES, pH 7.0) was added to both sides of the sample cell. Then about 2 / 3 of the electrolyte solution of the sample cell was aspirated from the -cis end with a 1 mL pipette. When the average current was close to 0 pA, the electrolyte solution was driven to the -cis side of the sample cell to form a planar phospholipid bilayer. After the phospholipid membrane was formed, the PaMscS1 protein solution was added to the -cis end. When PaMscS1 was embedded in the planar phospholipid bilayer, the current changed significantly. After the protein was embedded, 1 mL of solution was replaced and subsequent experiments were performed.

[0116] Single Nucleotide Detection:

[0117] Different groups of amplification products were detected by MscS angstrom pores. Different samples were added to the -cis end, and the current was recorded and observed at +50 mV for 20 minutes. When a stable PaMscS1 angstrom pore was formed on the planar phospholipid membrane, the single nucleotide to be detected was added to the -cis end of the sample pore, and then a voltage was applied and the current signal was recorded.

[0118] Embodiment 2

[0119] Electrophysiological detection and dNTPs detection based on PaMscS angstrom pore:

[0120] The basic function of MscS is a fast on / off switch that responds to mechanical stimuli, such as changes in membrane tension during osmotic stress. The cytoplasmic domain of MscS functions as a molecular sieve that balances the loss of osmolytes during osmoadaptation. In the protein angstrom pore of the present invention, the seven side pores from the cytoplasmic region play a key role in the translocation of ions and solutes. Therefore, the side pore mutants PaMscS1 (W130A) and PaMscS2 (K180R) were selected for subsequent studies due to their low background noise ( Figure 4 , Figure 5 AC). In electrophysiological experiments, the purified protein was added to the -cis end of the electrophysiological device ( Figure 1 A). When the PaMscS mutant channel was embedded in a bilayer lipid membrane (BLM, a type of insulating membrane), a stable channel current jump was observed at a voltage of +50 mV ( Figure 1 B). The channel conductance of PaMscS1 remains stable at voltages ranging from -50 mV to +50 mV ( Figure 1 C), and when the voltage is higher than +90 mV, the gating probability of PaMscS1 increases ( Figure 6 The conductance of the PaMscS1 angstrom pore is 0.64±0.02nS (n=91, peak value±SD of Gaussian fitting, -cis end: 300mMNaCl, -trans end: 30mMNaCl), and the conductance distribution of the PaMscS2 angstrom pore is 34.9±7.0pA (mean±SD, from 18 independent insertion events) ( Figure 1 D) The ion transport results of PaMscS1 showed that PaMscS1 has better selectivity for Br- ( Figure 7 ).

[0121] When the PaMscS1 Å hole is inserted into the BLM and dNTPs are present in the -cis end, the translocation signal of dNTPs can be observed under positive voltage. The translocation frequency of dNTPs increases with the increase of voltage ( Figure 8Both PaMscS1 and PaMscS2 were analyzed for dNTP mixture detection (dNTPs concentration: 0.2mM, voltage: +50mV, -cis end: 300mMNaCl, -trans end: 30mMNaCl). Clear differences in the blockade current distributions were observed between the two mutants, indicating that the translocation of dNTPs is associated with the side pores of the PaMscS angstrom pore ( Figure 1 E). That is, under the same detection conditions, the distribution of the blocking current of dNTPs for PaMscS1 and PaMscS2 angstroms is different. Specifically, the blocking rate of PaMscS1 angstroms for the four dNTPs mixtures shows three peaks, while the blocking rate of PaMscS2 angstroms for the four dNTPs mixtures shows two peaks. Because the difference between the mutations of PaMscS1 and PaMscS2 lies in the difference in the amino acids of the side pores, it is speculated that the detection signal of dNTPs is related to the side pores. Since PaMscS1 has a better discrimination effect on dNTPs mixtures, it is more suitable for distinguishing dNTPs mixtures. As for PaMscS2, it exhibits a more stable channel conductance and a relatively higher membrane fusion efficiency, so it is more suitable for subsequent rapid diagnosis ( Figure 5 AC). The wild-type PaMscS angstrom pore showed two peaks in blocking rate for the four dNTPs mixtures ( Fig.12 ). The current trajectory and residence time distribution of PaMscS1 detecting single nucleotides are shown in Figure 2. Fig. 9 shown.

[0122] Compared with the currently reported nanopores containing am7βCD, MoS2 and α-Hederin, although the detection accuracy of the PaMscS1 angstrom pore is lower than that of the best reported biological nanopore containing am7βCD conjugate (i.e., constructed using α-hemolysin mutant protein and 6-amino-6-deoxy-β-cyclodextrin aptamer), the translocation speed is comparable to that of solid-state nanopores. In the single-stranded DNA (ssDNA) detection experiment, 50μM ssDNA was detected under the buffer conditions of 30mM NaCl / 300mM NaCl and +50mV bias voltage, and no translocation events were observed due to its narrow channel size ( Fig.10 ). Therefore, the PaMscS angstrom pore has the potential to be a useful small molecule sensor.

[0123] Embodiment 3

[0124] Selective tuning of the PaMscS1 angstrom pore for optimized dNTPs detection:

[0125] Considering the mechanical sensitivity of PaMscS1 angstrom pore, the selectivity of PaMscS1 angstrom pore was adjusted by applying different osmotic pressure differences. In order to maintain the constant charge characteristics of dCTP and dGTP under different osmotic pressure differences, the concentration of the conductivity buffer at the -cis end was kept at 300mM and the concentration of the conductivity buffer at the -trans end was changed to change the osmotic pressure difference. The detection ability of PaMscS1 angstrom pore for large dGTP and small dCTP was tested under three osmotic pressure difference conditions, including symmetric conditions ( Figure 2 A, 300 mM NaCl / 300 mM NaCl, +50 mV bias voltage), low osmotic pressure difference condition ( Figure 2 B, 100 mM NaCl / 300 mM NaCl, +50 mV bias voltage) and high osmotic pressure difference conditions ( Figure 2 C, 30 mM NaCl / 300 mM NaCl, +50 mV bias voltage). Under symmetric osmotic pressure conditions, the translocation frequency of dCTP increased from 0.16 ± 0.03 s -1 Increased to 0.22±0.07s -1 , while dGTP from 0.09±0.02s -1 Change to 0.07±0.003s -1 Under low osmotic pressure difference (LOD) conditions, the translocation frequency of dCTP increased from 0.34 ± 0.1 s -1 Increased to 0.67±0.14s -1 , while dGTP from 0.06±0.01s -1 Increase to 0.3±0.04s -1 Under high osmotic pressure difference (HOD) conditions, the translocation frequency of dCTP increased from 0.12 ± 0.04 s -1 Increased to 0.22±0.07s -1 , while dGTP from 0.37±0.08s -1 Increased to 1.12±0.12s -1 ( Figure 2 D, n = 3 per experiment, mean ± SEM). Figure 2 E summarizes the detection of dGTP and dCTP, and it is concluded that the low osmotic pressure difference condition shows the highest increase in translocation events for dCTP, while the high osmotic pressure difference condition shows the highest increase in translocation events for dGTP ( Figure 2 E) Compared with the reduced capture efficiency of dCTP under high osmotic pressure conditions, low osmotic pressure difference conditions show balanced capture capabilities for both dCTP and dGTP. Therefore, adjusting different osmotic pressure differences can more accurately capture different dNTPs.

[0126] In summary, given that the size and charge properties of dGTP and dCTP remain constant under given experimental conditions, and that the channel size of the MscS family (e.g., EcMscS, HpMscS, AtMsL1 proteins, etc.) can vary under different pressures, osmotic pressure conditions, or membrane potentials, the experimenters can conclude that the differences in selectivity of the PaMscS1 angstrom pore for dNTPs are caused by changes in channel size under different osmotic pressure gradient conditions.

[0127] Embodiment 4:

[0128] Detection of multiple biomarkers through PaMscS1 angstrom pores:

[0129] The experimenters designed a dNTP barcode probe differentiation strategy and verified its application in the detection of multiple biomarkers through the PaMscS1 angstrom pore. The specific operation is: two probes are designed to bind to the target DNA sequence and cause specific dNTPs consumption in the chain polymerization reaction. The principle is: probe A and probe B have different base distributions. When amplification occurs, the amplification of probe A or probe B can cause a large amount of consumption of its rich bases. By judging the main type of base consumption, the information of which probe it is can be obtained. Probe A: miR21 probe: includes a sequence complementary to miR21 and a polyT barcode sequence; Probe B: AFP aptamer probe: includes a sequence complementary to the AFP aptamer and a poly C barcode sequence. When probe A or probe B is present in the sample, the polymerase chain reaction can be activated to consume dATP or dGTP in the reaction system ( Figure 3 A) The results of non-denaturing PAGE electrophoresis of miR21 and AFP aptamer are shown in Fig.11 shown.

[0130] The control sample without target sequence, the sample with miR21, the sample with AFP aptamer and the sample with both miR21 and AFP aptamer were tested. The corresponding current traces and blockade current distributions are shown in Figure 2. Figure 3 B and 3C. It can be observed that in the control group (samples without miR21 and AFP aptamer), dATP (δf dATP =f dATP / f 背景 The relative increase in the frequency of translocation events of dGTP (δf dGTP =f dGTP / f 背景 ) had a relative increase in the frequency of translocation events of 1.8 ± 0.03. In samples with miR21, δf dATPwas significantly lower than that of the control group (1.4±0.1, mean±SEM). dGTP For samples with both miR21 and AFP aptamer, δf dATP (1.1±0.2, mean±SEM) and δf dGTP (1.3±0.2, mean±SEM) were decreased ( Figure 3 D) These results indicate that PaMscS1 can detect single or multiple biomarkers simultaneously by designing single or multiple specific probes (n≥3 for each experiment).

[0131] Embodiment five:

[0132] A strategy to enhance the signal:

[0133] A. Enhance the detection limit of the object to be detected by ion regulation, specifically for dNTPs, by adding divalent cations such as nickel ions and cobalt ions to the cytoplasmic end of the angstrom pore involved in the present invention, the detection limit of dNTPs can be improved; B. Enhance the signal-to-noise ratio by regulating the osmotic difference of the conductive liquid, specifically by increasing the concentration of the conductive liquid, the ability to distinguish drug molecules with similar structures can be improved, and by increasing the osmotic difference of the conductive liquid on both sides of the phospholipid membrane, the detection effect of dGTP can be improved.

[0134] Embodiment six:

[0135] Electrophysiological detection based on EcMscS angstrom pore

[0136] When wild-type EcMscS channels were embedded in a bilayer lipid membrane (BLM), a stable channel current jump was observed at a voltage of +100 mV ( Fig.13 ). The wild-type EcMscS channel current remained stable at voltages ranging from -100 mV to +100 mV ( Fig.14 The conductance of the wild-type EcMscS angstrom pore is 0.334±0.028nS (-cis end: 300mM NaCl, -trans end: 30mM NaCl) ( Fig.15 ). Fig.16 ac show the structures of EcMscS, TtMscS and HpMscS, respectively, which are highly similar to the structure of PaMscS, that is, they are all radially symmetrical and cylindrically shaped heptamer structures. Fig.16 ac and Fig.16d The sequences of PaMscS were further compared with those of EcMscS, TtMscS, and HpMscS (sequence information is shown in Table 3 below). The results showed that EcMscS, TtMscS, HpMscS and PaMscS have certain homology, but this homology is not highly homologous. The similarity between EcMscS and PaMscS is only 60%, but both of them have the ability to detect analytes. Therefore, those skilled in the art can understand that the key to determining that bacterial MscS can be used as an angstrom pore to detect analytes lies in its radially symmetrical and cylindrical heptamer structure and channel pore size, not just homology.

[0137] Table 3: Amino acid sequence information of four MscS

[0138] The embodiments of the present invention are described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned specific implementation modes, which are merely illustrative rather than restrictive. Under the guidance of the present invention, ordinary technicians in this field can also make many forms without departing from the scope of protection of the present invention and the claims, all of which are within the protection of the present invention.

[0139] References 1.Liu,H.&Johnston,APRAProgrammable SensortoProbetheInternalizationofProteins andNanoparticles inLive Cells.AngewandteChemieInternationalEdition52,5744–5748 (2013). 2.Li,X.etal.PlantDNAbarcoding:fromgene togenome.BiologicalReviews90,157–166 (2015). 3.Wilson,P.M.etal.Anovel fluorescence-basedassayfortherapiddetectionandquantificationofcellular deoxyribonucleosidetriphosphates.NucleicAcidsResearch39,e112–e112(2011).4.Fuller,C.W.etal.Real-time single-moleculeelectronic DNA sequencingby synthesis using polymer-taggednucleotides onananopore array.ProceedingsoftheNationalAcademy of Sciences ofthe UnitedStates ofAmerica113,5233–5238(2016). 5.Butler,T.Z.,Pavlenok,M.,Derrington,I.M.,Niederweis,M.&Gundlach,J.H. Single-moleculeDNAdetectionwithanengineeredMspAproteinnanopore.Proceedings of theNationalAcademy ofSciences105,20647–20652(2008). 6.Goyal,P.etal.Structural andmechanistic insights into thebacterialamyloid secretionchannelCsgG.Nature516,250–253(2014). 7.Cao,C.etal.Mappingthe sensing spots ofaerolysinforsingleoligonucleotides analysis. Nature Communications9,2823(2018). 8.Wendell,D.etal.Translocationofdouble-strandedDNAthroughmembrane-adaptedphi29 motorproteinnanopores.NatureNanotechnology4,765–772(2009). 9.Manrao,E.A.etal.Reading DNA at single-nucleotideresolutionwithamutantMspA nanopore andphi29 DNApolymerase.NatureBiotechnology30,349–353(2012). 10.Bowden,R.et al.Sequencing ofhuman genomes with nanoporetechnology.Nature Communications10,1869(2019). 11.Wang,Y.,Zheng,D.,Tan,Q.,Wang,M.X.&Gu,L.-Q.Nanopore-based detectionof circulating microRNAs in lung cancer patients.Nature Nanotechnology6,668–674(2011).12.Thakur,A.K.&Movileanu,L.Real-time measurement ofprotein–protein interactions at single-molecule resolution using a biological nanopore.NatureBiotechnology37,96–104 (2019). 13.Astier,Y.,Braha,O.&Bayley,H.Toward single molecule DNA sequencing:Direct identification ofribonucleoside and deoxyribonucleoside 5′-monophosphates by using an engineered protein nanopore equipped with a molecular adapter.JournaloftheAmerican Chemical Society128,1705–1710(2006). 14.Clarke,J.et al.Continuous base identification for single-moleculenanopore DNA sequencing. Nature nanotechnology4,265–70(2009). 15.Jeong,K.-B.et al.Alpha-Hederin Nanopore for Single NucleotideDiscrimination.ACS Nano13,1719–1727(2019). 16.Venta,K.et al.Differentiation ofShort,Single-Stranded DNAHomopolymers in Solid-StateNanopores.ACSNano7,4629–4636(2013). 17.Garaj,S.et al.Graphene as a subnanometre trans-electrodemembrane.Nature467,190–193 (2010). 18.Booth,I.R.&Blount,P.The MscS and MscL Families ofMechanosensitiveChannels Act asMicrobial Emergency Release Valves.Journal ofBacteriology194,4802–4809(2012). 19.Akitake,B.,Anishkin,A.&Sukharev,S.The“Dashpot”Mechanism ofStretch-dependent Gating in MscS.TheJournal ofGeneralPhysiology125,143–154(2005). 20.Bass,R.B.Crystal Structure ofEscherichia coli MscS,a Voltage-Modulated and Mechanosensitive Channel.Science298,1582–1587(2002). 21.Lee,J.-Y.,Na,I.Y.,Park,Y.K.&Ko,K.S.Genomic variations betweencolistin-susceptibleand-resistant Pseudomonas aeruginosa clinical isolatesand their effects on colistin resistance. Journal ofAntimicrobial Chemotherapy69,1248–1256(2014). 22.Machiyama,H.,Tatsumi,H.&Sokabe,M.Structural changes in thecytoplasmic domain of the mechanosensitive channel MscS duringopening.Biophysicaljournal97,1048–57(2009).23.Feng,J.et al.Identificationofsingle nucleotides in MoS2 nanopores.Nature Nanotechnology10,1070–1076(2015). 24.Gamini,R.,Sotomayor,M.,Chipot,C.&Schulten,K.Cytoplasmic DomainFilter Function inthe Mechanosensitive Channel ofSmall Conductance.BiophysicalJournal101,80–89(2011).25.Perozo,E.&Rees,D.C.Structure and mechanism inprokaryotic mechanosensitive channels. Current Opinion in StructuralBiology13,432–442(2003). 26.Maksaev,G.&Haswell,E.S.MscS-Like10 is a stretch-activated ionchannel from Arabidopsis thaliana with a preference for anions.ProceedingsoftheNationalAcademy of Sciences109,19015–19020(2012). 27.Rozevsky,Y.et al.Quantification ofmRNA Expression Using Single-Molecule Nanopore Sensing.ACSnano acsnano.0c06375(2020).doi:10.1021 / acsnano.0c06375 28.Ouldali,H.et al.Electrical recognition ofthe twenty proteinogenicamino acids using an aerolysin nanopore.Nature biotechnology38,176–181(2020). 29.LEI,J.&FRANK,J.Automated acquisition ofcryo-electron micrographsfor single particle reconstruction on an FEI Tecnai electron microscope.JournalofStructuralBiology150,69–80 (2005). 30.Zheng,S.Q.et al.MotionCor2:anisotropic correction ofbeam-inducedmotion for improved cryo-electron microscopy.Nature Methods14,331–332(2017). 31.Punjani,A.,Rubinstein,J.L.,Fleet,D.J.&Brubaker,M.A.cryoSPARC:algorithms for rapidunsupervised cryo-EM structure determination.NatureMethods14,290–296(2017). 32.Punjani,A.,Zhang,H.&Fleet,D.J.Non-uniform refinement:Adaptiveregularization improves single particle cryo-EM reconstruction.bioRxiv2019.12.15.877092(2019). doi:10.1101 / 2019.12.15.877092 33.Wang,W.et al.The Structure ofan Open Form ofan E.coliMechanosensitive Channel at 3.45 A Resolution.Science321,1179–1183(2008). 34.Jurcik,A.et al.CAVER Analyst 2.0:analysis and visualizationofchannels and tunnels in protein structures and molecular dynamics trajectories.Bioinformatics(Oxford,England)34, 3586–3588(2018). 35.Smart,O.S.,Goodfellow,J.M.&Wallace,B.A.The pore dimensionsofgramicidin A. Biophysicaljournal65,2455–60(1993). 36.Kefauver,J.M.,Ward,A.B.&Patapoutian,A.Discoveries in structureandphysiology ofmechanically activated ion channels.Nature 587,567–576(2020). 37.Hurst AC,Petrov E,Kloda A,Nguyen T,Hool L,Martinac B.MscS,thebacterial mechanosensitive channel ofsmall conductance.IntJBiochem CellBiol.2008;40(4):581-585. 38.Malcolm,H.R.and Maurer,J.A.(2012),The Mechanosensitive ChannelofSmall Conductance(MscS) Superfamily:Not Just Mechanosensitive Channels Anymore.ChemBioChem,13:2037-2043。

Claims

1. A method for detecting nucleotides in a sample, characterized in that: The steps include: S1: adding the sample to an angstrom system, the angstrom system comprising: an angstrom, an insulating film, a first medium, and a second medium, wherein the angstrom is embedded in the insulating film, the insulating film separates the first medium from the second medium, the angstrom provides a channel connecting the first medium and the second medium, the angstrom is an MscS angstrom, the angstrom has a radially symmetrical and cylindrical heptamer structure, the heptamer structure comprises 7 side openings and 1 bottom opening; the sample is added to the first medium; S2 applies a driving force to the first medium and the second medium, and the nucleotides in the sample interact with the angstrom pore and generate an electrical signal; S3 analyzes the electrical signal to identify the nucleotides in the sample.

2. The method according to claim 1, characterized in that The charge property and / or pore size of the opening is adjustable; the adjustment method of the opening optionally includes subjecting the insulating membrane to mechanical force stimulation and / or changing the physical state of the insulating membrane, and the mechanical force stimulation optionally includes one or more of the change in osmotic pressure difference of the medium on both sides of the insulating membrane, direct physical stimulation of the insulating membrane by microneedles, and stimulation of the insulating membrane by negative air pressure.

3. The method according to claim 1, characterized in that The aperture of the opening can be adjusted in the following ways: (1) Selection of the types of the first medium and the second medium; and / or (2) The osmotic pressure difference between the first medium and the second medium.

4. The method according to claim 3, characterized in that The osmotic pressure difference between the first medium and the second medium is adjusted by the concentration difference between the first medium and the second medium, and the concentration difference between the first medium and the second medium is optionally about 0-270 mM.

5. The method according to claim 1, characterized in that The Angstrom pore is a MscS variant Angstrom pore, and the MscS variant optionally includes a side pore volume variant and / or a side pore charge variant.

6. The method according to claim 1, characterized in that The emphipores are derived from bacilli, and may optionally include one or more of Pseudomonas aeruginosa, Escherichia coli, Thermoanaerobacterium Tengchongensis, and Helicobacter pylori.

7. The method according to claim 1, characterized in that The angstrom pore is a PaMscS variant angstrom pore, optionally including one or more of the following variants: 130A, 130H, 180R, 271I, 130S and 130P.

8. The method according to claim 1, characterized in that The nucleotides include one or more of dGTP, dATP, dTTP, dCTP, dUTP, GTP, ATP, TTP, CTP, and UTP.

9. A nucleotide rapid detection kit, characterized in that: The kit comprises: (1) an MscS angstrom pore, wherein the MscS angstrom pore optionally comprises a side pore volume variant and / or a side pore charge variant of MscS; (2) an insulating membrane, optionally comprising a phospholipid membrane and / or a polymer membrane; (3) An electroconductive liquid, wherein the electroconductive liquid optionally includes one or more of a sodium chloride solution, a lithium chloride solution, a cesium chloride solution, a potassium chloride solution and a sodium bromide solution.

10. The kit according to claim 9, characterized in that The angstrom pore is a PaMscS variant angstrom pore, optionally including one or more of 130A, 130H, 180R, 271I, 130S and 130P.